Elisa Bono

4.0k total citations · 1 hit paper
36 papers, 2.1k citations indexed

About

Elisa Bono is a scholar working on Immunology, Hematology and Molecular Biology. According to data from OpenAlex, Elisa Bono has authored 36 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 11 papers in Hematology and 10 papers in Molecular Biology. Recurrent topics in Elisa Bono's work include Acute Myeloid Leukemia Research (10 papers), T-cell and B-cell Immunology (9 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Elisa Bono is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), T-cell and B-cell Immunology (9 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Elisa Bono collaborates with scholars based in Italy, United States and United Kingdom. Elisa Bono's co-authors include Francesco Sinigaglia, Fabio Gallazzi, Juergen Hammer, Zoltán Á. Nagy, Tiziana Sturniolo, Laura Raddrizzani, Michael Braxenthaler, Oezlem Tuereci, Jiayi Ding and Maria Pia Protti and has published in prestigious journals such as Nature Genetics, The Journal of Experimental Medicine and Blood.

In The Last Decade

Elisa Bono

35 papers receiving 2.1k citations

Hit Papers

Generation of tissue-specific and promiscuous HLA ligand ... 1999 2026 2008 2017 1999 200 400 600

Peers

Elisa Bono
Thomas J. Sproule United States
Loren D. Erickson United States
Chungwen Wei United States
Graham P. Cook United Kingdom
Luc Reininger Switzerland
Miriam A. Shelef United States
Anastas Pashov United States
Annaiah Cariappa United States
Thomas J. Sproule United States
Elisa Bono
Citations per year, relative to Elisa Bono Elisa Bono (= 1×) peers Thomas J. Sproule

Countries citing papers authored by Elisa Bono

Since Specialization
Citations

This map shows the geographic impact of Elisa Bono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Bono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Bono more than expected).

Fields of papers citing papers by Elisa Bono

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Bono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Bono. The network helps show where Elisa Bono may publish in the future.

Co-authorship network of co-authors of Elisa Bono

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Bono. A scholar is included among the top collaborators of Elisa Bono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Bono. Elisa Bono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Molteni, Elisabetta, Elisa Bono, Anna Gallì, et al.. (2023). Prevalence and clinical expression of germ line predisposition to myeloid neoplasms in adults with marrow hypocellularity. Blood. 142(7). 643–657. 9 indexed citations
2.
Donnici, Lorena, Luca Ferrante, Pietro Di Lucia, et al.. (2022). Discovery and antiviral profile of new sulfamoylbenzamide derivatives as HBV capsid assembly modulators. Bioorganic & Medicinal Chemistry Letters. 73. 128904–128904. 4 indexed citations
3.
Bono, Elisa, et al.. (2022). Mastocytosis: Fertility and Pregnancy Management in a Rare Disease. Frontiers in Oncology. 12. 874178–874178. 2 indexed citations
4.
Giovanni, Marco De, Amir Giladi, Chiara Medaglia, et al.. (2020). Spatiotemporal regulation of type I interferon expression determines the antiviral polarization of CD4+ T cells. Nature Immunology. 21(3). 321–330. 53 indexed citations
5.
Piacentini, Luca, Elisa Bono, Elena Tremoli, et al.. (2020). Gene-expression profiles of abdominal perivascular adipose tissue distinguish aortic occlusive from stenotic atherosclerotic lesions and denote different pathogenetic pathways. Scientific Reports. 10(1). 6245–6245. 8 indexed citations
6.
Gemelli, Maria, Elena Maria Elli, Chiara Elena, et al.. (2020). Use of generic imatinib as first-line treatment in patients with chronic myeloid leukemia (CML): the GIMS (Glivec to Imatinib Switch) study. Blood Research. 55(3). 139–145. 6 indexed citations
7.
Chiesa, Mattia, Luca Piacentini, Elisa Bono, et al.. (2020). Whole blood transcriptome profile at hospital admission discriminates between patients with ST-segment elevation and non-ST-segment elevation acute myocardial infarction. Scientific Reports. 10(1). 8731–8731. 12 indexed citations
8.
Saporiti, Federica, Luca Piacentini, Valentina Alfieri, et al.. (2019). Melanocortin-1 Receptor Positively Regulates Human Artery Endothelial Cell Migration. Cellular Physiology and Biochemistry. 52(6). 1339–1360. 9 indexed citations
9.
Bono, Elisa, Donal P. McLornan, Erica Travaglino, et al.. (2019). Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndrome. Leukemia. 33(10). 2495–2505. 60 indexed citations
10.
Bono, Elisa, Donal P. McLornan, Erica Travaglino, et al.. (2017). Hypoplastic Myelodysplastic Syndrome: Clinical, Histopathological and Molecular Characterization. Blood. 130. 588–588. 1 indexed citations
11.
Malcovati, Luca, Anna Gallì, Erica Travaglino, et al.. (2016). Predictive Value of Mutation Analysis in the Diagnostic Approach to Patients with Unexplained Cytopenia. Blood. 128(22). 298–298. 1 indexed citations
12.
Castiglioni, Laura, Francesca Colazzo, Gualtiero I. Colombo, et al.. (2015). Evaluation of Left Ventricle Function by Regional Fractional Area Change (RFAC) in a Mouse Model of Myocardial Infarction Secondary to Valsartan Treatment. PLoS ONE. 10(8). e0135778–e0135778. 8 indexed citations
13.
Gotti, Manuel, Valeria Fiaccadori, Elisa Bono, et al.. (2013). Therapy-Related Late Adverse Events in Hodgkin’s Lymphoma. INFM-OAR (INFN Catania). 2013. 1–7. 8 indexed citations
14.
Ambaglio, Ilaria, Luca Malcovati, Elli Papaemmanuil, et al.. (2013). Inappropriately low hepcidin levels in patients with myelodysplastic syndrome carrying a somatic mutation of SF3B1. Haematologica. 98(3). 420–423. 45 indexed citations
15.
Rogge, Lars, Elisabetta Bianchi, Mauro Biffi, et al.. (2000). Transcript imaging of the development of human T helper cells using oligonucleotide arrays. Nature Genetics. 25(1). 96–101. 201 indexed citations
16.
Raddrizzani, Laura, Elisa Bono, Anne B. Vogt, et al.. (1999). Identification of destabilizing residues in HLA class II-selected bacteriophage display libraries edited by HLA-DM. European Journal of Immunology. 29(2). 660–668. 30 indexed citations
17.
Pistillo, Maria Pia, et al.. (1997). A Novel Approach to Human Anti-HLA mABs Production: Use of Phage Display Libraries. Human Immunology. 57(1). 19–26. 7 indexed citations
18.
Raddrizzani, Laura, Tiziana Sturniolo, Jeanmarie Guenot, et al.. (1997). Different modes of peptide interaction enable HLA-DQ and HLA-DR molecules to bind diverse peptide repertoires. The Journal of Immunology. 159(2). 703–711. 50 indexed citations
19.
Hammer, Juergen, Fabio Gallazzi, Elisa Bono, et al.. (1995). Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association.. The Journal of Experimental Medicine. 181(5). 1847–1855. 255 indexed citations
20.
Hammer, Juergen, Elisa Bono, Fabio Gallazzi, et al.. (1994). Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning.. The Journal of Experimental Medicine. 180(6). 2353–2358. 245 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026